logging in or signing up Carbabenems%20and%20monobactams%2017092005[1] ikabu Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 9 Category: Entertainment License: All Rights Reserved Like it (0) Dislike it (0) Added: February 12, 2012 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript CARBAPENEMS: CARBAPENEMS e.g. Imipenem / Cilastatin Meropenem Imipenem / Cilastatin, i.v Mechanism of action Similar to other B. lactams Antibacterial spectrum Aerobic & anaerobic G+ & G- bacteria, including pseudomonads and most enterobacter. MRSA is less sucebtibleIMIPENEM / CILASTATIN ( CONT. ): IMIPENEM / CILASTATIN ( CONT. ) Pharmacokinetics Not absorbed orally ( i.v infusion ) Partly broken down by dehydropeptidase in the proximal tubule- given with cilastatin ( dihydropeptidase inhibitor ) Excreted primarily by the kidney Doses must be reduced in renal failure Half- life about 1 hrPowerPoint Presentation: Clinical uses of imipenem / cilastatin Infections require multiple antibiotics ( useful in nosocomial infections ) Not used alone for serious pseud.infections Not used for MRSA infectionsPowerPoint Presentation: Side effects Similar to those seen with B- lactams Nausea & vomiting are frequent Excessive levels with renal failure may lead to seizures Pts allergic to penicillins may be allergic to imipenemPowerPoint Presentation: Disadvantages of Imipenem / cilastatin vs Meropenem High incidence of seizures, whereas meropenem is not. A 1g of imip./cilas require 200 ml saline to dissolve, whereas A 1g of meropenem dissolves in only 20 ml saline. Hence, meropenem can be given either by i.v bolus or i.v infusion Whereas, Imip./cilas should be given only by i.v infusion, so: Less suitable for fluid restricted pts Not suitable for outpatients- need hospitalizationMONOBACTAMS: MONOBACTAMS AZTREONAM Mechanism of action Similar to other B- lactams Antibacterial spectrum Active only against G- aerobic bacteria (pseudomonads, N. gonorrhea, N. meningitidis, H. influenzae and enterobacteriaceae ) Inactive against G+ and anaerobic bacteriaAZTREONAM ( CONT. ): AZTREONAM ( CONT. ) Pharmacokinetics Poorly absorbed orally( i.v / 8 hr ) Limited penetration into the CSF Excreted primarily by the kidney Half- life 2 hr Side effects Similar to other B- lactams. Pts allergic to penicillins and cephalosporins can receive aztreonamPowerPoint Presentation: Clinical uses of aztreonam Active against G- aerobes only Alternative for penicillins ( piperacillin ) and cephalosporins ( ceftazidime ) allergic pts for G- infections Safe alternative to aminoglycosides, esp. in elderly and pts with renal impairements You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Carbabenems%20and%20monobactams%2017092005[1] ikabu Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 9 Category: Entertainment License: All Rights Reserved Like it (0) Dislike it (0) Added: February 12, 2012 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript CARBAPENEMS: CARBAPENEMS e.g. Imipenem / Cilastatin Meropenem Imipenem / Cilastatin, i.v Mechanism of action Similar to other B. lactams Antibacterial spectrum Aerobic & anaerobic G+ & G- bacteria, including pseudomonads and most enterobacter. MRSA is less sucebtibleIMIPENEM / CILASTATIN ( CONT. ): IMIPENEM / CILASTATIN ( CONT. ) Pharmacokinetics Not absorbed orally ( i.v infusion ) Partly broken down by dehydropeptidase in the proximal tubule- given with cilastatin ( dihydropeptidase inhibitor ) Excreted primarily by the kidney Doses must be reduced in renal failure Half- life about 1 hrPowerPoint Presentation: Clinical uses of imipenem / cilastatin Infections require multiple antibiotics ( useful in nosocomial infections ) Not used alone for serious pseud.infections Not used for MRSA infectionsPowerPoint Presentation: Side effects Similar to those seen with B- lactams Nausea & vomiting are frequent Excessive levels with renal failure may lead to seizures Pts allergic to penicillins may be allergic to imipenemPowerPoint Presentation: Disadvantages of Imipenem / cilastatin vs Meropenem High incidence of seizures, whereas meropenem is not. A 1g of imip./cilas require 200 ml saline to dissolve, whereas A 1g of meropenem dissolves in only 20 ml saline. Hence, meropenem can be given either by i.v bolus or i.v infusion Whereas, Imip./cilas should be given only by i.v infusion, so: Less suitable for fluid restricted pts Not suitable for outpatients- need hospitalizationMONOBACTAMS: MONOBACTAMS AZTREONAM Mechanism of action Similar to other B- lactams Antibacterial spectrum Active only against G- aerobic bacteria (pseudomonads, N. gonorrhea, N. meningitidis, H. influenzae and enterobacteriaceae ) Inactive against G+ and anaerobic bacteriaAZTREONAM ( CONT. ): AZTREONAM ( CONT. ) Pharmacokinetics Poorly absorbed orally( i.v / 8 hr ) Limited penetration into the CSF Excreted primarily by the kidney Half- life 2 hr Side effects Similar to other B- lactams. Pts allergic to penicillins and cephalosporins can receive aztreonamPowerPoint Presentation: Clinical uses of aztreonam Active against G- aerobes only Alternative for penicillins ( piperacillin ) and cephalosporins ( ceftazidime ) allergic pts for G- infections Safe alternative to aminoglycosides, esp. in elderly and pts with renal impairements